Development and validation of a hedgehog heparin-binding assay for high-throughput screening

Sonic hedgehog (Shh) is a morphogenic protein with critical roles in embryogenesis and the development of some cancers. Hence, identifying inhibitors of the Shh pathway is of great therapeutic value. Heparin and HSPGs act as crucial modulators of Shh activity. To identify molecules that antagonize S...

Full description

Bibliographic Details
Main Authors: David R. Lamson, Mark A. Hughes, Audrey F. Adcock, Ginger R. Smith, Kevin P. Williams
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:MethodsX
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2215016120304271
_version_ 1818968860982771712
author David R. Lamson
Mark A. Hughes
Audrey F. Adcock
Ginger R. Smith
Kevin P. Williams
author_facet David R. Lamson
Mark A. Hughes
Audrey F. Adcock
Ginger R. Smith
Kevin P. Williams
author_sort David R. Lamson
collection DOAJ
description Sonic hedgehog (Shh) is a morphogenic protein with critical roles in embryogenesis and the development of some cancers. Hence, identifying inhibitors of the Shh pathway is of great therapeutic value. Heparin and HSPGs act as crucial modulators of Shh activity. To identify molecules that antagonize Shh binding to heparin we have developed a solid-phase plate-based assay. The N-terminal domain of Shh (ShhN) protein is first coated in 384-well plates and the direct binding of fluorescein-labeled heparin (flu-heparin) assessed by measuring the fluorescence signal after incubation and wash steps. Binding of ShhN protein to the 384-well plates was confirmed and optimized by a standard ELISA using a monoclonal antibody recognizing folded ShhN. The assay was validated using whole plate minimum and maximum signal wells with a Z’ of 0.68–0.75 determined. Herein, we describe the development and validation of a high throughput screen to identify small molecule antagonists of Shh heparin binding.Overall, this method • Results in an optimized and validated assay for hedgehog heparin binding. • Delivers a cost effective high-throughput screen format for hedgehog heparin antagonist screening
first_indexed 2024-12-20T14:11:25Z
format Article
id doaj.art-b7668e3874d54d878013dd3217d4b70a
institution Directory Open Access Journal
issn 2215-0161
language English
last_indexed 2024-12-20T14:11:25Z
publishDate 2021-01-01
publisher Elsevier
record_format Article
series MethodsX
spelling doaj.art-b7668e3874d54d878013dd3217d4b70a2022-12-21T19:38:07ZengElsevierMethodsX2215-01612021-01-018101207Development and validation of a hedgehog heparin-binding assay for high-throughput screeningDavid R. Lamson0Mark A. Hughes1Audrey F. Adcock2Ginger R. Smith3Kevin P. Williams4Biomanufacturing Research Institute and Technology Enterprise, United StatesBiomanufacturing Research Institute and Technology Enterprise, United StatesBiomanufacturing Research Institute and Technology Enterprise, United StatesBiomanufacturing Research Institute and Technology Enterprise, United StatesBiomanufacturing Research Institute and Technology Enterprise, United States; Department of Pharmaceutical Sciences, North Carolina Central University, Durham, NC 27707, United States; Corresponding author at: Biomanufacturing Research Institute and Technology Enterprise, United States.Sonic hedgehog (Shh) is a morphogenic protein with critical roles in embryogenesis and the development of some cancers. Hence, identifying inhibitors of the Shh pathway is of great therapeutic value. Heparin and HSPGs act as crucial modulators of Shh activity. To identify molecules that antagonize Shh binding to heparin we have developed a solid-phase plate-based assay. The N-terminal domain of Shh (ShhN) protein is first coated in 384-well plates and the direct binding of fluorescein-labeled heparin (flu-heparin) assessed by measuring the fluorescence signal after incubation and wash steps. Binding of ShhN protein to the 384-well plates was confirmed and optimized by a standard ELISA using a monoclonal antibody recognizing folded ShhN. The assay was validated using whole plate minimum and maximum signal wells with a Z’ of 0.68–0.75 determined. Herein, we describe the development and validation of a high throughput screen to identify small molecule antagonists of Shh heparin binding.Overall, this method • Results in an optimized and validated assay for hedgehog heparin binding. • Delivers a cost effective high-throughput screen format for hedgehog heparin antagonist screeninghttp://www.sciencedirect.com/science/article/pii/S2215016120304271Hedgehog heparin HTS assay
spellingShingle David R. Lamson
Mark A. Hughes
Audrey F. Adcock
Ginger R. Smith
Kevin P. Williams
Development and validation of a hedgehog heparin-binding assay for high-throughput screening
MethodsX
Hedgehog heparin HTS assay
title Development and validation of a hedgehog heparin-binding assay for high-throughput screening
title_full Development and validation of a hedgehog heparin-binding assay for high-throughput screening
title_fullStr Development and validation of a hedgehog heparin-binding assay for high-throughput screening
title_full_unstemmed Development and validation of a hedgehog heparin-binding assay for high-throughput screening
title_short Development and validation of a hedgehog heparin-binding assay for high-throughput screening
title_sort development and validation of a hedgehog heparin binding assay for high throughput screening
topic Hedgehog heparin HTS assay
url http://www.sciencedirect.com/science/article/pii/S2215016120304271
work_keys_str_mv AT davidrlamson developmentandvalidationofahedgehogheparinbindingassayforhighthroughputscreening
AT markahughes developmentandvalidationofahedgehogheparinbindingassayforhighthroughputscreening
AT audreyfadcock developmentandvalidationofahedgehogheparinbindingassayforhighthroughputscreening
AT gingerrsmith developmentandvalidationofahedgehogheparinbindingassayforhighthroughputscreening
AT kevinpwilliams developmentandvalidationofahedgehogheparinbindingassayforhighthroughputscreening